AbbVie
ABBV
ABBV
3,130 hedge funds and large institutions have $196B invested in AbbVie in 2023 Q1 according to their latest regulatory filings, with 159 funds opening new positions, 1,245 increasing their positions, 1,357 reducing their positions, and 117 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
8% less repeat investments, than reductions
Existing positions increased: 1,245 | Existing positions reduced: 1,357
13% less funds holding in top 10
Funds holding in top 10: 348 → 303 (-45)
23% less capital invested
Capital invested by funds: $255B → $196B (-$58.3B)
Holders
3,130
Holding in Top 10
303
Calls
$3.15B
Puts
$2.04B
Top Buyers
| 1 | +$1.91B | |
| 2 | +$660M | |
| 3 | +$381M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$329M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$273M |
Top Sellers
| 1 | -$665M | |
| 2 | -$460M | |
| 3 | -$435M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$418M |
| 5 |
Boston Partners
Boston,
Massachusetts
|
-$324M |